3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
15
Active not recruiting
11
Recruiting
9
Terminated
7
Not yet recruiting
6
Withdrawn
3
Unknown
2
Sponsor Class
OTHER
2
Study Type
Observational
3
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Urinary Bladder Neoplasms
2
Interventions
Cisplatin
504
Cyclophosphamide
353
Radiotherapy
349
Carboplatin
347
Capecitabine
328
Oxaliplatin
319
Paclitaxel
316
Gemcitabine
315
Docetaxel
308
Fluorouracil
281
apatinib
240
Drug Therapy
239
Bevacizumab
224
camrelizumab
212
Etoposide
199
Irinotecan
176
Doxorubicin
174
Dexamethasone
159
Leucovorin
158
sintilimab
140
Pemetrexed
136
Cytarabine
136
pembrolizumab
135
anlotinib
135
toripalimab
124
S 1 (combination)
119
Neoadjuvant Therapy
119
Vincristine
118
Rituximab
114
Radiosurgery
113
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Interventional
×
Cystectomy
×
Clear all
NCT04391790
2023-04-27
MOSAIC
Aarhus University Hospital
Phase NA
Unknown
300 enrolled
NCT03529890
2022-10-20
RACE IT
Technical University of Munich
Phase 2
Unknown
33 enrolled